ArticleFrontiers in pharmacology2025

Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.

Sireen Abdul Rahim Shilbayeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.